HHS and FDA launch review of abortion pill mifepristone after disputed safety study, sparking backlash from abortion rights advocates.

Lucknow: Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) introduced a new QR code to make it easier for patients and healthcare workers to report Adverse Drug Reactions, also known as drug ...

Can yoga work if you can’t stand? Yes, chair yoga helps seniors build strength, balance, reduce pain, and improve mood.

Trump, rescheduling, and the future of cannabis: chaos, risk, and opportunity as operators navigate federal change, markets, and policy evolution.

Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients with treatment-resistant depression and demonstrated rapid, clinically ...

A major climate change report has laid out a dire future. Meanwhile Minister Murray Watt has handed another win to Woodside.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of ...

Minimal residual disease (MRD)-guided retreatment with anti-CD20 antibodies could significantly improve outcomes in patients with high-risk, relapsed chronic lymphocytic leukemia (CLL), according to a ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data ...

President Donald Trump posted an AI version of himself promoting a fake product called “medbeds” to his 10.8 million followers on Truth Social Friday night. The clip takes the form of a phony Fox News ...

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...

During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of ...